Assessing the feasibility of the GOTT (Gabapentinoid and Opioid Tapering Toolkit) in a primary care setting in North-East England.

IF 1.3 Q4 CLINICAL NEUROLOGY British Journal of Pain Pub Date : 2024-10-20 DOI:10.1177/20494637241291534
Lucy Johnson, Frances Cole, Rebecca Kinchin, Andrea Francis, Konrad Winiarek, Kate Hampshire, Paul Chazot
{"title":"Assessing the feasibility of the GOTT (Gabapentinoid and Opioid Tapering Toolkit) in a primary care setting in North-East England.","authors":"Lucy Johnson, Frances Cole, Rebecca Kinchin, Andrea Francis, Konrad Winiarek, Kate Hampshire, Paul Chazot","doi":"10.1177/20494637241291534","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To assess the feasibility and possible impacts of implementation of systematic non-pharmacological interventions to reduce the level of prescribing of opioid and gabapentinoid analgesics for chronic non-cancer pain (CNCP), particularly high-dose prescriptions, through a proof-of-concept study in a deprived area (second lowest decile) primary care practice in North-East England.</p><p><strong>Participant: </strong>Twenty-five primary care staff (clinical and non-clinical) of which 18 clinicians received the intervention.</p><p><strong>Intervention used in this study practice known as gott gabapentinoid and opioid toolkit: </strong>All clinicians received an educational skills programme to support patient pain self-management, tailored on the clinicians' self-assessment of their learning needs, embedding both clinician skill learning and patient self-care resources for rapid access within consultations into a GP clinical management computer system.</p><p><strong>Outcome measures: </strong>Clinical staff completed questionnaires before and after the GOTT intervention to assess levels of knowledge and confidence in their own skills to support chronic pain self-management across several domains. Prescription data were used to measure changes in opioid and gabapentinoid prescribing at the practice across the 12-month intervention and 30-month follow-up period.</p><p><strong>Results: </strong>Prescribing of opioid and gabapentinoid/pregabalin decreased substantially in the practice across the intervention period (c. 90% in high-dose opioid [<i>p</i> = .0118], and 15% gabapentin/pregabalin prescriptions, respectively), over a one-year period during the COVID-19 pandemic. Follow-up analysis showed 100% and c.50% reductions, respectively, in December 2022. The questionnaire data showed an increase in clinician confidence in skills to enable self-management over the intervention period, overall (<i>p</i> = .044) and, specifically across three of the five domains measured: supporting behavioural change (<i>p</i> = .028), supporting self-care (<i>p</i> = .008), and managing difficult consultations (<i>p</i> = .011).</p><p><strong>Conclusion: </strong>The GOTT intervention program provided some initial evidence of a proof-of-concept for the implementation of a systematic non-pharmacological pain management skills and resources programme addressing lack of confidence in skills to introduce and support self-management and reduce use of strong opioids and gabapentinoids.</p>","PeriodicalId":46585,"journal":{"name":"British Journal of Pain","volume":" ","pages":"20494637241291534"},"PeriodicalIF":1.3000,"publicationDate":"2024-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559511/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Pain","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/20494637241291534","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To assess the feasibility and possible impacts of implementation of systematic non-pharmacological interventions to reduce the level of prescribing of opioid and gabapentinoid analgesics for chronic non-cancer pain (CNCP), particularly high-dose prescriptions, through a proof-of-concept study in a deprived area (second lowest decile) primary care practice in North-East England.

Participant: Twenty-five primary care staff (clinical and non-clinical) of which 18 clinicians received the intervention.

Intervention used in this study practice known as gott gabapentinoid and opioid toolkit: All clinicians received an educational skills programme to support patient pain self-management, tailored on the clinicians' self-assessment of their learning needs, embedding both clinician skill learning and patient self-care resources for rapid access within consultations into a GP clinical management computer system.

Outcome measures: Clinical staff completed questionnaires before and after the GOTT intervention to assess levels of knowledge and confidence in their own skills to support chronic pain self-management across several domains. Prescription data were used to measure changes in opioid and gabapentinoid prescribing at the practice across the 12-month intervention and 30-month follow-up period.

Results: Prescribing of opioid and gabapentinoid/pregabalin decreased substantially in the practice across the intervention period (c. 90% in high-dose opioid [p = .0118], and 15% gabapentin/pregabalin prescriptions, respectively), over a one-year period during the COVID-19 pandemic. Follow-up analysis showed 100% and c.50% reductions, respectively, in December 2022. The questionnaire data showed an increase in clinician confidence in skills to enable self-management over the intervention period, overall (p = .044) and, specifically across three of the five domains measured: supporting behavioural change (p = .028), supporting self-care (p = .008), and managing difficult consultations (p = .011).

Conclusion: The GOTT intervention program provided some initial evidence of a proof-of-concept for the implementation of a systematic non-pharmacological pain management skills and resources programme addressing lack of confidence in skills to introduce and support self-management and reduce use of strong opioids and gabapentinoids.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
评估加巴喷丁和阿片类药物减量工具包(GOTT)在英格兰东北部基层医疗机构的可行性。
目的通过在英格兰东北部一个贫困地区(第二低十分位数)的初级医疗实践中开展概念验证研究,评估实施系统性非药物干预措施的可行性和可能产生的影响,以减少慢性非癌性疼痛(CNCP)阿片类和加巴喷丁类镇痛药的处方量,尤其是大剂量处方:25 名初级保健人员(临床和非临床),其中 18 名临床医生接受了干预措施:所有临床医生都接受了一项支持患者疼痛自我管理的教育技能计划,该计划是根据临床医生对其学习需求的自我评估而量身定制的,将临床医生技能学习和患者自我护理资源嵌入到全科医生临床管理计算机系统中,以便在会诊期间快速获取:临床人员在 GOTT 干预前后填写了调查问卷,以评估他们对自己在多个领域支持慢性疼痛自我管理技能的知识水平和信心。处方数据用于衡量该诊所在 12 个月干预期和 30 个月随访期阿片类药物和加巴喷丁类药物处方的变化情况:结果:在 COVID-19 大流行期间的一年时间里,干预期间的阿片类药物和加巴喷丁/普瑞巴林处方量大幅减少(大剂量阿片类药物处方量减少约 90% [p = 0.0118],加巴喷丁/普瑞巴林处方量减少约 15%)。后续分析显示,到 2022 年 12 月,处方量分别减少了 100%和 c.50%。问卷调查数据显示,在干预期间,临床医生对自我管理技能的信心总体上有所提高(p = .044),特别是在五个测量领域中的三个领域:支持行为改变(p = .028)、支持自我护理(p = .008)和处理疑难会诊(p = .011):GOTT 干预计划为实施系统的非药物疼痛管理技能和资源计划提供了一些初步的概念验证证据,以解决对引入和支持自我管理技能缺乏信心的问题,并减少强阿片类药物和加巴喷丁类药物的使用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
British Journal of Pain
British Journal of Pain CLINICAL NEUROLOGY-
CiteScore
3.20
自引率
11.10%
发文量
42
期刊介绍: British Journal of Pain is a peer-reviewed quarterly British journal with an international multidisciplinary Editorial Board. The journal publishes original research and reviews on all major aspects of pain and pain management. Reviews reflect the body of evidence of the topic and are suitable for a multidisciplinary readership. Where empirical evidence is lacking, the reviews reflect the generally held opinions of experts in the field. The Journal has broadened its scope and has become a forum for publishing primary research together with brief reports related to pain and pain interventions. Submissions from all over the world have been published and are welcome. Official journal of the British Pain Society.
期刊最新文献
Community opioid dispensing after rib fracture injuries: CODI study. Persistent postsurgical pain in hip fracture patients. A prospective longitudinal study with multifaceted assessment. Costs of physician and diagnostic imaging services for shoulder, knee, and low back pain conditions: A population-based study in Alberta, Canada. The value of social relationships in the biopsychosocial model of pain. Assessing the feasibility of the GOTT (Gabapentinoid and Opioid Tapering Toolkit) in a primary care setting in North-East England.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1